Sentinel node biopsy in breast cancer.

Area of Science:

• Oncology
• Surgical Pathology

Background:

• Regional lymph node status is a key prognostic factor in solid tumors.
• Sentinel nodes are the first lymph nodes to receive lymphatic drainage from a tumor.
• Accurate staging of lymph node involvement is critical for treatment planning.

Purpose of the Study:

• To review the methodology and significance of sentinel lymph node biopsy.
• To evaluate the potential for avoiding axillary lymph node dissection in breast cancer.

Main Methods:

• Sentinel node identification using vital dyes (e.g., isosulfan blue) or radiolabeled tracers (e.g., technetium-Tc-99m).
• Preoperative scintigraphy and immediate preoperative staining techniques.
• Histopathological examination of extirpated sentinel nodes and comparison with other axillary nodes.

Main Results:

• Sentinel lymph node biopsy is an established technique for staging nodal involvement.
• Studies demonstrate that precise criteria allow for the selection of breast cancer patients who can avoid complete axillary dissection.
• Accurate sentinel node assessment can prevent morbidity associated with unnecessary lymphadenectomy.

Conclusions:

• Sentinel lymph node biopsy is a reliable method for assessing regional lymph node metastasis.
• Avoiding complete axillary dissection in select breast cancer patients is feasible and beneficial.
• This approach enhances patient outcomes by minimizing surgical complications.